- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05796609
Design and Evaluation of an In-Vehicle Real-Time Drunk Driving Detection System (DRIVE)
Randomized, Controlled, Interventional Single-Centre Study for the Design and Evaluation of an In-Vehicle Real-Time Drunk Driving Detection System - The DRIVE Test Track Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Driving under the influence of alcohol (or "drunk driving") is one of the most significant causes of traffic accidents. Alcohol consumption impairs neurocognitive and psychomotor function and has been shown to be associated with an increased risk of driving accidents. However, autonomous driving (level 4 or 5) is likely to be broadly available only at a substantially later time point than previously thought due to increasing concerns of safety associated with this technology. Therefore, solutions bridging the upcoming time period by more rapidly and directly addressing the problem of drunk driving associated traffic incidents are urgently needed.
On the supposition that driving behavior differs significantly between sober state and drunk state, the investigators assume that different driving patterns of people under alcohol influence compared to sober states can be used to generate drunk driving detection models using machine learning algorithms. In this study, driving for data collection is initially performed at a sober baseline state (no alcohol) and then after alcohol administration (with a target of 0.15 mg/l and 0.35 mg/l breath alcohol concentration).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3008
- Institut für Rechtsmedizin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informed consent as documented by signature.
- In possession of a definite Swiss or EU driving license.
- At least 21 years old
- Active driving in the last 6 months.
- No special equipment needed when driving.
- Drinks alcohol at least occasionally (moderate/social consumption).
- Fluent in (Swiss) German and no speech impairment.
Exclusion Criteria:
- Health concerns that are incompatible with alcohol consumption.
- Any potential participant currently taking illegal drugs or medications that interact with alcohol.
- Women who are pregnant or breast feeding.
- Intention to become pregnant during the course of the study.
- Teetotallers (alcohol abstinent persons).
- Alcohol misuse (excessive alcohol consumption habits/risky drinking behaviour (according to WHO definition) and/or the biomarker PEth in capillary blood > 200 ng/mL at first visit.
- Known or suspected drug abuse within 4 weeks before the study (e.g., positive urine drug test at first visit).
- Non-compliance to alcohol abstinence within 24 hours before the study visits.
- Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant.
- Participation in another study with investigational drug within the 30 days preceding and during the present study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment Group
Driving under the influence of alcohol Aware of the possible induction of alcohol (purpose of the study), but blinded to the actual amount and target blood alcohol concentration |
Participants will drive in three different states (sober, drunk above and below the legal limit) on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial sober driving session, participants are administered pre-mixed alcoholic beverages (e.g., vodka orange). Participants are expected to achieve a target breath alcohol concentration of 0.35 mg/l (legal limit in Switzerland is 0.25 mg/l breath alcohol concentration) before the second driving session starts. Finally, the third driving session starts when the participants' breath alcohol concentration drops to 0.15 mg/l. Participants will be blinded to their alcohol levels during the study. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration |
|
No Intervention: Reference Group
Driving without the influence of alcohol or placebo Fully informed |
|
|
Placebo Comparator: Placebo Group
Driving under the influence of a placebo Not informed (blinded) |
Participants will drive three times at the same intervals as the treatment group on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial driving session, participants receive placebo beverages (e.g., orange juice with vodka flavor). Participants are fully blinded. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of the drunk driving warning system (DRIVE) to detect states of alcohol influence while driving quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC)
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on in-vehicle data generated in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of the drunk driving warning system using physiological data to detect states of alcohol influence quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC)
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on physiological wearable data recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Diagnostic accuracy of the drunk driving warning system using eye-tracking data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on eye-tracking data recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Diagnostic accuracy of the drunk driving warning system using controller area network data of the study car to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on controller area network data of the study car recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Diagnostic accuracy of the drunk driving warning system using audio data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on audio data recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Diagnostic accuracy of the drunk driving warning system using radar sensor data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on radar sensor data recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Diagnostic accuracy of the drunk driving warning system using gas sensor data to detect states of alcohol influence quantified as the AUROC
Time Frame: 480 minutes
|
The machine learning model is developed and evaluated based on gas sensor data recorded in different states of alcohol intoxication.
Detection performance of alcohol influence is quantified as AUROC.
|
480 minutes
|
|
Change of steering over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Steering is recorded based on the controller area network.
|
480 minutes
|
|
Change of steer torque over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Steer torque is recorded based on the controller area network.
|
480 minutes
|
|
Change of steer speed over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Steer speed is recorded based on the controller area network.
|
480 minutes
|
|
Change of velocity over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Velocity is recorded based on the controller area network.
|
480 minutes
|
|
Change of acceleration over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Acceleration is recorded based on the controller area network.
|
480 minutes
|
|
Change of braking over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Braking is recorded based on the controller area network.
|
480 minutes
|
|
Change of swerving over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Swerving is recorded based on the controller area network.
|
480 minutes
|
|
Change of spinning over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Spinning is recorded based on the controller area network.
|
480 minutes
|
|
Change of gaze position over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Gaze position is recorded using an eye-tracker device.
|
480 minutes
|
|
Change of gaze velocity over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Gaze velocity is recorded using an eye-tracker device.
|
480 minutes
|
|
Change of gaze acceleration over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Gaze acceleration is recorded using an eye-tracker device.
|
480 minutes
|
|
Change of gaze regions of interest over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Gaze regions of interest (e.g., windshield, car dashboard, etc.) are recorded using an eye-tracker device.
|
480 minutes
|
|
Change of gaze events over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Gaze events (e.g., fixations, saccades, etc.) are recorded using an eye-tracker device.
|
480 minutes
|
|
Change of head pose over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Head pose (position/rotation) is recorded using an eye-tracker device.
|
480 minutes
|
|
Change of heart rate over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Heart rate is recorded using a heart rate monitoring device and wearables.
|
480 minutes
|
|
Change of heart rate variability over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Heart rate variability is recorded using a heart rate monitoring device and wearables.
|
480 minutes
|
|
Change of electrodermal activity over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Electrodermal activity is recorded using wearables.
|
480 minutes
|
|
Change of wrist accelerometer measurements over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Wrist accelerometer measurements are recorded using wearables.
|
480 minutes
|
|
Change of skin temperature over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Skin temperature is recorded using wearables.
|
480 minutes
|
|
Self-assessment of driving performance over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Participants rate their driving performance on a 7-point Likert Scale (lower value means poorer driving performance).
|
480 minutes
|
|
Self-estimation of alcohol concentrations over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Participants estimate their blood alcohol concentration.
|
480 minutes
|
|
Number of driving mishaps over the alcohol intoxication trajectory
Time Frame: 480 minutes
|
Any driving mishaps, accidents and interventions by the driving instructor will be documented.
|
480 minutes
|
|
Number of Adverse Events (AEs)
Time Frame: 3 months, from screening to close out visit for each participant
|
Adverse Events will be recorded at each study visit.
|
3 months, from screening to close out visit for each participant
|
|
Number of Serious Adverse Events (SAEs)
Time Frame: 3 months, from screening to close out visit for each participant.
|
Serious Adverse Events will be recorded at each study visit.
|
3 months, from screening to close out visit for each participant.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wolfgang Weinmann, Prof. Dr., University of Bern
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Neoplasms by Site
- Neoplasms
- Heart Diseases
- Neoplasms by Histologic Type
- Thoracic Neoplasms
- Drinking Behavior
- Congenital Abnormalities
- Abnormalities, Multiple
- Neoplasms, Connective and Soft Tissue
- Neoplasms, Connective Tissue
- Skin Abnormalities
- Myxoma
- Heart Neoplasms
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Behavior
- Criminal Behavior
- Dangerous Behavior
- Alcohol Drinking
- Carney Complex
- Driving Under the Influence
- Organic Chemicals
- Alcohols
- Ethanol
Other Study ID Numbers
- DRIVE Test Track
- SNCTP000005396 (Registry Identifier: Swiss National Clinical Trials Portal)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Penn State UniversityNot yet recruiting
-
Boston University Charles River CampusActive, not recruiting
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
University of WyomingRecruiting
-
Binghamton UniversityNot yet recruitingUnderage Drinking | Drinking, Teen | Adolescent Alcohol UseUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
The University of Hong KongRecruitingmHealth Intervention | AlcoholHong Kong
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
Clinical Trials on Driving under the influence of alcohol
-
University of BernETH Zurich; University of St.GallenCompletedAlcohol Drinking | Impaired Driving | Transportation Accidents | Drunk DrivingSwitzerland
-
University of ZurichCompleted
-
Iacob Czihac Emergency Military Clinical HospitalCompleted
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Hospices Civils de LyonCompleted
-
NDR Medical Technology Pte LtdUniversity of MalayaCompleted
-
Ospedale di Circolo - Fondazione MacchiCompletedInfant Conditions | Infant Behavior | Infant MorbidityItaly
-
Seoul National University HospitalTerminatedBispectral Index, Monitored Anesthesia CareKorea, Republic of
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedOxidative Stress | Hyperoxia | Rhinoplasty | Oxygen Reserve IndexTurkey (Türkiye)
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingStroke Patients With ConstipationChina